News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
680,672 Results
Type
Article (40175)
Company Profile (199)
Press Release (640298)
Section
Business (204358)
Career Advice (1970)
Deals (35534)
Drug Delivery (78)
Drug Development (81002)
Employer Resources (167)
FDA (16074)
Job Trends (14839)
News (345299)
Policy (32856)
Tag
Academia (2571)
Africa (722)
Allergies (39)
Alliances (49587)
Alzheimer's disease (1108)
Antibody-drug conjugate (ADC) (45)
Approvals (16017)
Arizona (159)
Artificial intelligence (48)
Asia (37402)
Australia (6032)
Bankruptcy (352)
Best Places to Work (11221)
Biosimilars (59)
C2C Services and Suppliers (79309)
California (824)
Canada (641)
Cancer (181)
Career advice (1646)
CAR-T (34)
Cell therapy (69)
China (49)
Clinical research (62938)
Collaboration (59)
Colorado (33)
Compensation (30)
COVID-19 (2497)
Cystic fibrosis (70)
Diabetes (34)
Diagnostics (5924)
Diversity, equity & inclusion (44)
Drug pricing (49)
Earnings (82952)
Employer resources (141)
Europe (79697)
Events (107623)
FDA (16119)
Florida (106)
Funding (37)
Gene therapy (54)
GLP-1 (474)
Government (4369)
Healthcare (18606)
Hotbed/Location (483523)
Idaho (55)
Illinois (194)
Indiana (107)
Infectious disease (2510)
Inflammatory bowel disease (86)
Interviews (306)
IPO (16188)
Job creations (3657)
Job search strategy (1421)
Kansas (90)
Layoffs (377)
Legal (7877)
Liver cancer (52)
Lung cancer (40)
Maine (47)
Management (53)
Manufacturing (47)
Maryland (264)
Massachusetts (452)
Medical device (13013)
Medtech (13016)
Mergers & acquisitions (19045)
Metabolic disorders (157)
Neuroscience (1186)
New Jersey (62)
New York (83)
NextGen Class of 2024 (6493)
Non-profit (4470)
North Carolina (160)
Obesity (102)
Opinion (168)
Parkinson's disease (29)
Patents (33)
Peanut (35)
Pennsylvania (55)
People (55907)
Phase I (19537)
Phase II (27707)
Phase III (20740)
Policy (33)
Postmarket research (2558)
Preclinical (8344)
Rare diseases (91)
Real estate (5974)
Recruiting (63)
Regulatory (21346)
Reports (32)
Research institute (2339)
Resumes & cover letters (344)
South America (1102)
Startups (3601)
Texas (87)
United States (3026)
Vaccines (427)
Washington State (114)
Weight loss (96)
Date
Today (14)
Last 7 days (496)
Last 30 days (1800)
Last 365 days (38492)
2024 (21775)
2023 (40333)
2022 (51489)
2021 (56042)
2020 (54413)
2019 (46855)
2018 (35312)
2017 (32497)
2016 (31872)
2015 (37940)
2014 (31702)
2013 (26733)
2012 (28889)
2011 (29596)
2010 (27581)
680,672 Results for "sino biological inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sponsored
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological
Sino Biological, Inc. has successfully concluded the acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc.
July 15, 2024
·
3 min read
Deals
Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio
Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), specializing in...
April 26, 2024
·
4 min read
Business
Sino Biological Announces Services Partnership with Rapid Novor
Sino Biological, Inc., a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext, which provides biological research reagents and related technical contract research services, is pleased to announce the formation of a services partnership with Toronto, Canada-based Rapid Novor, Inc.
March 14, 2024
·
3 min read
InDevR and Sino Biological Team Up to Deliver Multiplexed Analytical Solutions for mRNA Vaccine and Cell & Gene Therapy
Partnership addresses biopharmaceutical industry’s urgent need for improved in-process and QC testing tools for these rapidly evolving application fields
June 5, 2024
·
3 min read
Business
Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing
Sino Biological, Inc. is pleased to announce the formal opening of its new Center for Bioprocessing (C4B) in Houston, Texas USA at Levit Green, adjacent to the world-renowned Texas Medical Center.
October 9, 2023
·
3 min read
Business
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.
June 28, 2024
·
4 min read
Pharm Country
Neurotech Pharmaceuticals, Inc. Receives Priority Review of Biologics License Application (BLA) for NT-501 (revakinagene taroretcel) as a Treatment for Macular Telangiectasia Type 2 (MacTel)
Neurotech Pharmaceuticals, Inc. announces that the U.S. Food and Drug Administration (FDA), has determined that the Biologic License Application (BLA) for NT-501, an investigational encapsulated cell therapy for the treatment of MacTel, is sufficiently complete to permit a substantive review.
June 20, 2024
·
3 min read
NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility
NurExone Biologic Inc., a pioneering biopharmaceutical company is pleased to announce that its common shares are now quoted for trading on the OTCQB® Venture Market under the symbol NRXBF.
April 25, 2024
·
4 min read
Business
Sino Biological Announces Construction of Its New US-Based Center for Bioprocessing
Sino Biological, Inc. is pleased to announce the formal signing of a lease with Hines and initiation of construction on its new Center for Bioprocessing at its Levit Green facility in Houston, Texas USA.
November 21, 2022
·
4 min read
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
Axogen, Inc. is pleased to announce that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License Application (BLA) for licensure of Avance Nerve Graft ® on May 15, 2024.
May 16, 2024
·
7 min read
1 of 68,068
Next
